Otello Stampacchia
CIK 1361712 · Chief Executive Officer · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MITI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BOSTON, MA 02199
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMA | Director | 455,361 | $4.05 | $1.84M | $8.00M | 2 | 2026-06-18 |
| ImageneBio, Inc. (IKNA) Delisted | Director | 149,927 | $17.16 | $2.57M | $0 | 5 | 2024-06-10 |
| Kronos Bio, Inc. (KRON) Delisted | Director | 3,818,283 | $0.88 | $3.36M | $8.55M | 3 | 2022-06-29 |
| REPL | Director | 4,811,245 | $12.47 | $60.00M | -$5.86M | 2 | 2021-11-18 |
| Morphic Holding, Inc. (MORF) Delisted | Director | 5,209,524 | $56.99 | $296.89M | -$39.44M | 9 | 2021-03-25 |
| Omega Alpha SPAC (OMEG) Delisted | Chief Executive Officer | 501,000 | $10.10 | $5.06M | $5.01M | 1 | 2021-01-13 |
| GOSS | Director | 86,245 | $9.15 | $789.1K | -$9.57M | 2 | 2019-09-12 |
| MICROMET, INC. (MITI) Delisted | Director | 45,048 | — | — | $24.72M | 25 | 2010-03-04 |
Recent Filings · Page 2 of 5
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-25 | Morphic Holding, Inc. (MORF) Delisted | Sell (S) | −209,256 | -$12.66M | EDGAR |
| 2021-03-19 | Morphic Holding, Inc. (MORF) Delisted | Sell (S) | −143,412 | -$9.19M | EDGAR |
| 2021-03-01 | Morphic Holding, Inc. (MORF) Delisted | Sell (S) | −143,956 | -$5.28M | EDGAR |
| 2021-02-25 | Morphic Holding, Inc. (MORF) Delisted | Sell (S) | −42,192 | -$1.44M | EDGAR |
| 2021-02-04 | Morphic Holding, Inc. (MORF) Delisted | Sell (S) | −216,496 | -$8.02M | EDGAR |
| 2021-02-02 | Morphic Holding, Inc. (MORF) Delisted | Sell (S) | −82,172 | -$2.77M | EDGAR |
| 2021-01-28 | REPL | Sell (S) | −121,400 | -$5.51M | EDGAR |
| 2021-01-21 | Morphic Holding, Inc. (MORF) Delisted | Sell (S) | −68,952 | -$2.07M | EDGAR |
| 2021-01-13 | Omega Alpha SPAC (OMEG) Delisted | Buy (P) | +501,000 | $5.01M | EDGAR |
| 2020-10-16 | Kronos Bio, Inc. (KRON) Delisted | Mixed | +3,798,832 | $14.47M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.